Japanese (NIKKEI) Healthcare Sector Analysis
UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies199
- 7D-3.1%
- 3M-5.2%
- 1Y1.8%
- YTD2.2%
Over the last 7 days, the Healthcare industry has dropped 3.1%, driven by a pullback from Daiichi Sankyo Company of 6.3%. Meanwhile, M3 actually outperformed within the industry, gaining 5.2% in the last week. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 13% annually.
Sector Valuation and Performance
Has the Japanese Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Feb 2023 | JP¥59.1t | JP¥32.6t | JP¥2.2t | 16x | 26.4x | 1.8x |
| Sun, 01 Jan 2023 | JP¥60.0t | JP¥32.4t | JP¥2.2t | 16x | 27.6x | 1.9x |
| Tue, 29 Nov 2022 | JP¥65.0t | JP¥32.4t | JP¥2.2t | 16.5x | 29.9x | 2x |
| Thu, 27 Oct 2022 | JP¥64.2t | JP¥31.7t | JP¥2.2t | 15.6x | 28.6x | 2x |
| Sat, 24 Sep 2022 | JP¥60.4t | JP¥31.7t | JP¥2.3t | 15.6x | 26.7x | 1.9x |
| Mon, 22 Aug 2022 | JP¥63.5t | JP¥31.7t | JP¥2.3t | 16x | 28x | 2x |
| Wed, 20 Jul 2022 | JP¥61.7t | JP¥31.3t | JP¥2.3t | 16.2x | 26.7x | 2x |
| Fri, 17 Jun 2022 | JP¥55.5t | JP¥31.3t | JP¥2.3t | 15.4x | 24x | 1.8x |
| Sun, 15 May 2022 | JP¥57.6t | JP¥31.3t | JP¥2.3t | 15.4x | 25.1x | 1.8x |
| Tue, 12 Apr 2022 | JP¥60.0t | JP¥30.8t | JP¥2.4t | 17.4x | 25.1x | 2x |
| Thu, 10 Mar 2022 | JP¥54.1t | JP¥30.8t | JP¥2.4t | 14.9x | 22.6x | 1.8x |
| Sat, 05 Feb 2022 | JP¥58.7t | JP¥30.6t | JP¥2.4t | 16.8x | 24.3x | 1.9x |
| Mon, 03 Jan 2022 | JP¥63.9t | JP¥30.3t | JP¥2.4t | 17.6x | 26.4x | 2.1x |
| Wed, 01 Dec 2021 | JP¥64.2t | JP¥30.3t | JP¥2.4t | 9.7x | 26.5x | 2.1x |
| Fri, 29 Oct 2021 | JP¥66.6t | JP¥29.9t | JP¥2.3t | 20.3x | 29x | 2.2x |
| Sun, 26 Sep 2021 | JP¥72.1t | JP¥29.4t | JP¥2.2t | 22x | 32.4x | 2.5x |
| Tue, 24 Aug 2021 | JP¥66.9t | JP¥29.5t | JP¥2.2t | 20.3x | 30.1x | 2.3x |
| Wed, 30 Jun 2021 | JP¥67.0t | JP¥29.5t | JP¥2.2t | 21.1x | 30.1x | 2.3x |
| Sat, 03 Apr 2021 | JP¥66.4t | JP¥28.7t | JP¥2.0t | 22.2x | 32.8x | 2.3x |
| Tue, 05 Jan 2021 | JP¥69.4t | JP¥28.6t | JP¥1.8t | 22.9x | 37.7x | 2.4x |
| Fri, 09 Oct 2020 | JP¥64.7t | JP¥28.5t | JP¥1.7t | 24.9x | 37.5x | 2.3x |
| Thu, 02 Jul 2020 | JP¥63.2t | JP¥28.6t | JP¥1.8t | 23.1x | 34.3x | 2.2x |
| Sun, 05 Apr 2020 | JP¥53.2t | JP¥28.9t | JP¥1.8t | 19.9x | 29.7x | 1.8x |
Price to Earnings Ratio
31.5x
Current Industry PE
- Investors are pessimistic on the Japanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 26.4x which is lower than its 3-year average PE of 30.2x.
- The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 6.5% per year over the last three years.
- Revenues for these companies have grown 4.4% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare sector?
| JP Market | -0.51% | |
| Healthcare | -3.11% | |
| Healthtech | 1.42% | |
| Healthcare Services | 0.13% | |
| Life Sciences | -0.013% | |
| Biotech | -0.64% | |
| Medical Equipment | -2.25% | |
| Pharma | -4.23% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 98.7x.
- Analysts are expecting annual earnings growth of 19.1%, which is higher than its past year's earnings growth of 11.2% per year.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 25% over the next 5 years.
- This is better than its past earnings decline of 48% per year.
- In contrast, the Life Sciences industry is expected to see its earnings grow by 3.0% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2413 M3 | JP¥3.72k | 5.2% +JP¥125.6b | -14.4% | PE53.6x | |
| 7733 Olympus | JP¥2.47k | 2.8% +JP¥83.4b | -4.2% | PE24.4x | |
| 4502 Takeda Pharmaceutical | JP¥4.17k | 0.9% +JP¥57.5b | 23.3% | PE23.6x | |
| 4543 Terumo | JP¥3.81k | 1.6% +JP¥44.7b | -10.2% | PE35.3x | |
| 6869 Sysmex | JP¥8.66k | 1.6% +JP¥28.9b | -20.7% | PE39.5x |